WallStreetZenWallStreetZen

NASDAQ: ANEB
Anebulo Pharmaceuticals Inc Earnings & Revenue

Buy ANEB

ANEB earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$33.6M
Current Profit Margin
0%

ANEB Return on Equity

Current Company
-173.8%
Current Industry
6.9%
Current Market
38.4%
ANEB's Return on Equity (-173.8%)... subscribe to Premium to read more.
High Return on Equity Performance

ANEB Return on Assets

Current Company
-171.6%
Current Industry
5.1%
ANEB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ANEB Return on Capital Employed

Current Company
-195.86%
Current Industry
-16.5%

ANEB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ANEB$0.00-$33.61M-$33.61MN/AN/A
CLGN$1.21M-$13.10M-$13.75M+18.22%N/A
SURF$30.55M-$56.77M-$62.96M-12.82%N/A
ANVS$0.00-$23.38M-$23.38MN/AN/A
AMAM$7.46M-$64.34M-$68.08M-14.97%N/A

Anebulo Pharmaceuticals Earnings & Revenue FAQ

What were ANEB's earnings last quarter?

Anebulo Pharmaceuticals (NASDAQ: ANEB) reported Q1 2022 earnings per share (EPS) of -$0.08, up 88.24% year over year. Total Anebulo Pharmaceuticals earnings for the quarter were -$1.88 million. In the same quarter last year, Anebulo Pharmaceuticals's earnings per share (EPS) was -$0.68.

If you're new to stock investing, here's how to buy Anebulo Pharmaceuticals stock.

What was ANEB's earnings growth in the past year?

As of Q3 2022, Anebulo Pharmaceuticals's earnings has grown year over year. Anebulo Pharmaceuticals's earnings in the past year totalled -$33.61 million.

What was ANEB's revenue last quarter?

Anebulo Pharmaceuticals (NASDAQ: ANEB) reported Q1 2022 revenue of $0.00 up N/A year over year. In the same quarter last year, Anebulo Pharmaceuticals's revenue was $0.00.

What was ANEB's revenue growth in the past year?

As of Q3 2022, Anebulo Pharmaceuticals's revenue has grown null year over year. Anebulo Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.